Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009
Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the Ministry of Food and Drug Safety for...
Search results for "Phase 3 clinical trial"
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate
Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name: anbalcabtagene autoleucel) was deemed...
Bundang CHA Hospital Develops Bone-Regeneration Scaffold Powered by Lactic Acid Signaling
When a fracture is severe or involves substantial bone loss, the body's natural regenerative capacity often falls short.
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits
Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct...
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
GC Pharma Partners with France’s Osivax to Develop Next-Generation Combination Flu Vaccine
GC Pharma has entered into a strategic partnership with French biotech firm Osivax to develop and commercialize a...
Stem Cell Pioneer Kim Dong-wook Wins KY Cha Academic Award for Breakthrough Parkinson’s Therapy
Professor Kim Dong-wook of Yonsei University College of Medicine, a pioneer in human embryonic stem cell-based...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Regenerative Technique Aims to Solve Rotator Cuff Re-Tears by Rebuilding the Tendon-Bone Junction
When surgeons reattach a torn shoulder tendon to the bone, a frustrating setback often occurs over time: the repair...
Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study
An animal study has revealed that combining GC Green Cross Wellbeing’s human placental hydrolysate treatment, Laennec...